Naproxen

CAT: 0804-HY-15030-01Size: 500 mgDry Ice: NoHazardous: No
CAT#:0804-HY-15030-01Size:500 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Naproxen is a COX-1 and COX-2 inhibitor with IC50s of 8.72 and 5.15 μM, respectively in cell assay.
CAS Number
[22204-53-1]
Product Name Alternative
(S) -Naproxen
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335, H361, H402, H411
Target
Autophagy; COX
Type
Reference compound
Related Pathways
Autophagy; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cancer
Assay Protocol
https://www.medchemexpress.com/Naproxen.html
Purity
99.98
Solubility
DMSO : ≥ 100 mg/mL|H2O : 75 mg/mL (ultrasonic; warming)
Smiles
C[C@H](C(O)=O)C1=CC2=CC=C(OC)C=C2C=C1
Molecular Formula
C14H14O3
Molecular Weight
230.26
Precautions
H302, H315, H319, H335, H361, H402, H411
References & Citations
[1]Mitchell JA, et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci U S A. 1993 Dec 15;90 (24) :11693-7.|[2]Rosa AC, et al. Prevention of bleomycin-induced lung inflammation and fibrosis in mice by naproxen and JNJ7777120 treatment. J Pharmacol Exp Ther. 2014 Nov;351 (2) :308-16.|[3]Krekels EH, et al. Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.
Shipping Conditions
Room Temperature
Storage Conditions
Store at room temperature 3 years
Scientific Category
Reference compound1
Clinical Information
Launched
Isoform
COX-1; COX-2

Alternative Products

CatalogName
M13544-01Naproxen
RM-N162428-01Naproxen EP Impurity G (R-Naproxen)
MBS3603691-01(R)-Naproxen
GP1103-25gNaproxen, 98%
MBS6060622-01rac-Naproxen
sc-358531A(R) -Naproxen
TRC-N377524-5MGNaproxen-d3
70-1063Naproxen antibody
41400043-3Naproxen Sodium
RM-N162444-01(+/-) -Naproxen D3

Popular Products